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Abstract 
Purpose: To compare the effectiveness of post-operative pain management and associated adverse 
effects of ketamine and nefopam. 
Methods: In total, 78 American Society of Anesthesiologists (ASA) grade 1 and 2 patients who had 
undergone abdominal surgery were given 3 mg of intravenous (IV) morphine as post-operative 
analgesia. Patients who still had pain were randomly selected (n = 48) and separated into three groups, 
and infused with isotonic saline (n = 15), 3 mg/kg/h ketamine (n = 17), or 3 mg/kg nefopam (n = 16), 
respectively. Verbal rating scale (VRS), visual analogue scale (VAS), satisfactory scores, and total 
morphine consumption, as well as several adverse events were determined. 
Results: VRS and VAS scores, and morphine consumption were significantly lower (p < 0.05) in the 
entire analgesic group than in the saline group. However, ketamine appeared to provide better (p < 
0.05) analgesic activity. The satisfactory score was concomitantly elevated (p < 0.05) in the ketamine 
group. Moreover, the occurrence of adverse events was substantially lower (p < 0.05) in the ketamine 
group and was equivalent to nefopam group except sedation.  
Conclusion: The combination of ketamine with morphine provides optimal pain relief in abdominal 
surgery patients and show fewer adverse effects than nefopam, thus achieving overall better 
satisfaction. 
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Post-operative pain continues to be a challenge 
and is often inadequately treated, leading to 
patient anxiety, stress, and dissatisfaction. 
Adequate analgesia within the beginning hours of 
the early post-operative period is important to 
curb the acute pain, which improves prognosis 
and prevents progression to chronic pain [1]. 
Post-operative pain is a major problem in 
surgical patients, especially after major 
abdominal surgery. Intravenous patient-
controlled analgesia (IV-PCA) is a well-
established technique for post-operative pain 
control. This technique prevents the patient from 
receiving excessive doses (overdosing), and it 
increases patient satisfaction and cooperation 
[2]. Morphine remains a gold standard analgesic 
used particularly for post-operative pain 
management. However, side effects tend to alter 
morphine titration, resulting in insufficient pain 
relief [3]. The combination of non-opioid 
analgesics with morphine provides a morphine-
sparing effect and may decrease dose-limiting 
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toxicity. The use of a combination of analgesics 
from different pharmacological drug classes to 
manage post-operative pain should improve the 
safety and efficacy of pain therapy due to their 
different mechanisms of action and by limiting 
the severity of adverse events of the individual 
drugs, since opioids alone sometimes provide 
insufficient post-operative analgesia. 
Understandably, a demand exists for the clinical 
investigation of drugs with special reference to 
adverse events, for analgesic use as part of 
combination therapy during the post-operative 
period [4]. 
 
Ketamine, an N-methyl-D-aspartate (NMDA) 
non-competitive antagonist, has undergone a 
recent resurgence of interest amongst acute care 
providers as an adjunct in acute pain 
management [5]. Several studies demonstrate 
that it improves opioid analgesia and decreases 
the need for opioids immediately after surgery 
[6,7]. Blocking NMDA receptors via magnesium-
dependent channels may improve the efficacy of 
opioids and reduce the risk of chronic pain 
syndromes [8]. Nefopam, a benzoxazine, is a 
cyclized analogue of diphenhydramine and a 
centrally acting, non-opioid analgesic. 
Intravenous (IV) infusion of nefopam quickly 
produces potent inhibition of the nociceptive 
flexion reflex in humans without binding to opiate 
receptors [9]. It provides morphine-sparing 
effects when given post-operatively during 
abdominal surgery [10]. In addition, nefopam 
indirectly modulates NMDA receptors and 
decreases c-Fos protein expression in the dorsal 
horn of the spinal cord in rats, and may reduce 
allodynia and hyperalgesia when combined with 
opioid [11]. Both ketamine and nefopam act as 
NMDA antagonists, modulating central 
sensitization and providing antihyperalgesic 
effects. Therefore, they could have a role in 
acute post-operative pain management by 
reducing the amount of opioids required and 
improving opioid effectiveness, which might also 
reduce their side effects. To the best of our 
knowledge, no studies have compared the 
efficacy and adverse effects of ketamine and 
nefopam as co-analgesics with morphine after 
major abdominal surgical procedures. Hence, the 
present study was aimed to evaluate whether 
these analgesic regimens improve recovery and 




A randomized, double-blind clinical trial was 
conducted in the post-anesthesia care unit 
(PACU) of Qilu Hospital of Shandong University 
in Jinan, China. The study was performed 
according to the guidelines of the Declaration of 
Helsinki [4] and was registered with the Chinese 
Clinical Trials Registry (CCTR no. 003241). All 
procedures involving human subjects were 
approved by the ethics committee of Qilu 
Hospital of Shandong University (approval ref no. 
QHSU-372849). Written informed consent was 




One hundred and twenty-four patients of both 
genders who were scheduled to undergo 
abdominal surgery (hemicolectomy, exploratory 
laparotomy, extended radical cystectomy and 
nephrectomy, and abdominal aortic aneurysm 
surgery), who were between the ages of 18 to 70 
years, and who were in good health or with mild 
systemic diseases according to the American 
Society of Anesthesiologists (ASA, grade 1 or 2) 
were recruited. Exclusion criteria were as follows: 
a psychiatric history, inability to understand the 
verbal rating scale (VRS) and the visual 
analogue scale (VAS), inability to use a patient-
controlled analgesia (PCA) device, previous 
treatment for chronic pain or treatment with 
opioids, known opioid allergies, chemical 
substance abuse, increased intracranial 
pressure, hepatic and renal pathology, and 
pregnancy. Patients undergoing emergency 
surgery were also excluded. During the pre-
anesthetic visit, the VRS and VAS were 
explained to patients, and they were trained to 
use PCA devices. Seventy-eight patients were 
enrolled after the initial assessment. 
 
Induction of general anesthesia 
 
General anesthesia was induced with 3.0 mg/kg 
fentanyl, 5 mg/kg thiopental sodium, and 1.5 
mg/kg succinylcholine. Atracurium was 
maintained with isoflurane in 50 % nitrous oxide 
and 0.3 – 1.3 µg/kg/min sufentanil [8]. 
Neuromuscular relaxation was antagonized at 
skin closure, and patients were tracheally 
extubated before transfer to the recovery room. 
After surgery, patients were given supplemental 




After arrival in the recovery room, residual 
neuromuscular blockade was reversed with 
neostigmine (40 µg/kg) and atropine (15 µg/kg) 
[8]. Post-operative pain was controlled by titration 
of IV morphine by nurses who were blinded to 
the grouping. The patients were administered 
morphine (3 mg/kg with a lockout time of 20 min 
until 1 h-programmed via IV-PCA infusion pump 
as post-operative analgesia in the recovery 
room. Patients who still experienced pain (VAS 
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score > 40, with no acute respiratory or 
hemodynamic distress) were included in the 
analysis (n = 48) and separated into three groups 
using computer-generated random numbers. The 
three groups were infused intravenously with 
isotonic saline (control group; n = 15), 3 mg/kg/h 
ketamine (ketamine group; n = 17), or 3 
mg/kg/nefopam (nefopam group; n = 16) 
respectively, followed by 3 mg/kg/h morphine via 
IV-PCA for 24 h or until pain subsided in the 
PACU. The morphine dose was subsequently 
reduced to determine morphine consumption, 
during which the following vitals were carefully 
monitored: pulse oximetry (SPO2), respiratory 
rate (RR), systolic and diastolic blood pressure 
(SBP and DBP), heart rate (HR), and 
temperature. 
 
Post-operative pain management and patient 
assessment 
 
The VRS was used to determine a patient’s self-
rated pain score verbally. Each patient selected a 
value on the scale that matched the degree of his 
or her pain at rest. The VRS ranged from 0-5, 
with the following scores: 0 = no pain, 1 = mild 
pain, 2 = moderate pain, 3 = severe pain, 4 = 
very severe pain (tolerable), and 5 = excruciating 
(intolerable) pain. The VAS consisted of a 
horizontal line 100 mm in length, with the end 
points ‘‘no pain’’ and ‘‘worst imaginable pain’’ 
placed at each end. Patients were instructed to 
mark the line at the level that best described their 
experienced pain intensity [12]. Patients were 
queried about their level of satisfaction using a 
satisfaction score on a Likert scale that ranged 
from 0-3, with the following scores: 0 = 
dissatisfied, 1 = least satisfied, 2 = partially 
satisfied, and 3 = fully satisfied, at 2, 6, 12 and 
24 h post-operatively. The morphine 
consumption rate and VRS and VAS scores were 
recorded at 0, 0.5, 1, 2, 6, 12 and 24 h. Adverse 
effects such as sedation, sweating, pruritus, 
dizziness, dry mouth, events related to 
respiratory rate (RR), and post-operative nausea 
and vomiting (PONV) were recorded at 24 h 
post-operatively. All post-operative parameters 
were recorded by an anesthesiologist and a 
certified registered nurse anesthetist (CRNA) 





Baseline characteristics (demographic data) 
were compared across the various groups using 
Student’s t-test. The incidence of side effects and 
the VRS and VAS scores were analyzed by the 
chi-square test and the Student’s t-test, and the 
values were expressed as means ± standard 
deviation (SD). One-way analysis of variance 
(ANOVA) was employed for comparisons among 
different groups. SPSS software version 17.0 
was used for all analyses. A value of p < 0.05 




Table 1 presents the demographic and clinical 
information of the patients in the three analgesic 
groups, including surgery duration and patient 
gender, weight, ASA status, and age. 
 
In total, 28 males (58 %) and 20 females (42 %) 
participated in the present study. No significant 
differences were noted in any of the 
demographic data. Moreover, the average 
duration of the various abdominal surgeries was 
between 2.5 and 3 h in all three groups. A 
flowchart of the study design is shown in Figure 
1. 
 
The mean rate of total morphine consumption 
was markedly lower in both the ketamine (p < 
0.01) and the nefopam (p < 0.05) groups 
compared with the control group (Fig 2). No 
significant differences in morphine consumption 
were noted between the nefopam and ketamine 
groups at 0, 0.5, 1, and 2 h post-operatively; 
however, slight differences were observed at 6, 
12, and 24 h. The mean cumulative dose of 
morphine administered during the 24 h period 
was 33.4 ± 2.5 mg, 25.13 ± 2.9 mg, and 26.94 ± 
3.5 mg in the control, ketamine (p < 0.01), and 
nefopam (p < 0.05) groups, respectively. Patients 
in the ketamine group consumed less morphine 
than those receiving nefopam or saline. 
 
Table 1: Demographic and clinical data 
  
Parameter Saline (n=15) Ketamine (n=17) Nefopam (n=16) 
Gender (M/F) 9/6 8/9 11/5 
Age (yr) 48.94 ± 9.42 51.30 ± 10.56 50.40 ± 11.47 
Weight (kg) 68.34 ± 10.31 71.52 ± 8.93 72.44 ± 11.25 
Height (cm) 166.78 ± 22.45 168.32 ± 28.98 170.22 ± 27.34 
ASA status (I/II) 11/4 12/5 12/4 
Duration of surgery (min) 158.57 ± 11.34 177.43 ± 30.95 169.32 ± 28.37 
Values are the mean ± SD. There were no statistically significant differences between the groups 
Li et al 




Figure 1: Flow chart of the present study design 
 
 
Figure 2: Morphine consumption rate of abdominal surgery undergone patients receiving saline, ketamine, or 
nefopam. Values are expressed as the mean ± SD; *p < 0.05, **p < 0.01 compared with the saline group 
 
The VRS and VAS scores were significantly 
higher in the control group than in the ketamine 
and nefopam groups at 1, 2, 6, and 12 h post-
operatively (Fig 3A and B). The pain scores of 
the control (morphine alone) and the nefopam 
and ketamine groups did not differ at 0 and 0.5 h. 
The average VRS and VAS scores of the 
ketamine group (p < 0.01) were lower than that 
of the nefopam (p < 0.05) group at 1, 2, 6, and 
12 h post-operatively. However, none of the 
patients indicated a VRS score of 0 or 1. 
Satisfaction scores were also higher in both the 
ketamine and nefopam groups compared with 
the saline group at 1, 2, 6, 12, and 24 h post-
operatively. Moreover, ketamine administration 
resulted in a superior satisfaction score 
compared with the other groups. Patients given 
nefopam rated their satisfaction as moderate (Fig 
4). 
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Figure 3: Post-abdominal surgery VRS (A) and VAS (B) scores of patients given saline, ketamine, or nefopam in 




Figure 4: Satisfaction scores of abdominal surgery patients given saline, ketamine, or nefopam in combination 
with morphine post-operatively. Values are expressed as the mean ± SD; *p < 0.05, **p < 0.01 compared with the 
saline group 
 
The incidence of various adverse effects is 
shown in Table 2. The overall occurrence of 
PONV was significantly higher in the control 
group than in the ketamine and nefopam groups. 
Only four patients in the nefopam group and one 
patient in the ketamine group had PONV. The 
percentage of patients who experienced 
sweating, pruritus, mouth dryness,  
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Table 2: Incidence of various adverse events, 24 h post-operative, in abdominal surgery patients given saline, 
ketamine, or nefopam in combination with morphine 
 
Variable Saline (n=15) Ketamine (n=17) Nefopam (n=16) 
Sedation 1 (6.6)* 3 (17.6)** - 
Sweating 2 (13.3)* - 1 (6.25)* 
Pruritus 2 (13.3)* - - 
Dizziness - - - 
Dry mouth 3 (20)** - 2 (12.5)* 
Respiratory rate 4 (26.6)* - - 
PONV 6 (40)** 1 (5.88) 4 (25)* 
Values are numbers of patients (%); *p < 0.05, **p < 0.01 compared to the other groups. PONV, post-operative 
nausea and vomiting 
 
and RR was significantly higher (p < 0.05) in the 
control (saline) group. None of the patients 
experienced dizziness. Sedation was observed in 
three patients in the ketamine group, while 
dryness of the mouth was reported in two 
patients in the nefopam group. The overall 
frequency of adverse events in the control group 
was much higher than that in the ketamine and 
nefopam groups. Patients in the ketamine group 
experienced no adverse effects except for 
sedation and PONV, and thus had the lowest 




This prospective study was designed to explore 
the efficacy of administering a combination of 
ketamine or nefopam with morphine (adjuvant 
therapy) to manage post-operative pain, as well 
as the associated incidence of adverse events, in 
abdominal surgery patients. Because morphine 
dose is limited by its toxicity, combining it with 
these drugs could provide better pain 
management, which would shorten hospital stays 
and enhance patient satisfaction. Major 
abdominal surgeries with upper abdominal 
incisions can result in severe abdominal pain if 
treated inadequately, and can cause shallow 
breathing and atelectasis, and thus, increase the 
incidence of post-operative morbidity and 
delayed recovery [13]. 
 
Low or sub-anesthetic doses of ketamine and 
nefopam, when combined with opioids, rarely 
induce adverse events or undesired 
hemodynamic alterations [14]. While morphine 
only delays the onset of NMDA receptor 
activation without direct inhibition, ketamine and 
nefopam are NMDA receptor antagonists. 
Therefore, it is logical to combine morphine with 
low doses of ketamine or nefopam to suppress 
hyperalgesia and the incidence of adverse 
effects produced by morphine. An opioid 
analgesic should be introduced and titrated to 
produce a maximum effect before a co-analgesic 
is added [15]. Hence, we used titrated morphine 
as an initial post-operative analgesic; if both 
drugs were introduced together, the risk of 
toxicity would increase and it would be difficult to 
determine the drug responsible for producing 
analgesia and/or any side effects. Thus, we 
followed this protocol to compare the effects of 
ketamine or nefopam combined with morphine. 
No demographic variables were significantly 
different between the treatment groups. 
 
The total morphine consumption was defined as 
the amount of morphine administered by the 
PCA device throughout the first 24 post-operative 
hours, excluding the initial morphine titration. 
Patients in the saline group consumed more 
morphine than those given ketamine or nefopam.  
Ketamine, an NMDA antagonist, has undergone 
a recent revival of interest amongst acute care 
providers as an adjunct in post-operative pain 
management. Blocking NMDA receptors may 
enhance the efficacy of opioids and reduce the 
development of chronic pain syndromes [8]. In 
2007, Galinski et al [16] concluded that ketamine 
reduced morphine consumption (administered by 
PCA) when compared with morphine alone, 
indicating that it has morphine-sparing activity.  
 
Nefopam also indirectly modulates NMDA 
receptors, decreases c-Fos expression in the 
dorsal horn of the spinal cord in rats, and may 
also reduce allodynia and hyperalgesia when 
combined with an opioid [11]. Thus, both 
ketamine and nefopam prevent neuronal 
hyperexcitability and reduce morphine 
consumption. Several studies have shown that 
both ketamine and nefopam have morphine-
sparing effects when administered after 
abdominal surgery [10,13,17-22]. However, 
ketamine led to lower morphine consumption 
than nefopam in this study. 
 
VRS and VAS are valid, reliable and appropriate 
tools for use in clinical practice to determine pain 
verbally and graphically, respectively, with 
patients attributing values that match the degree 
of pain experienced [23]. Saline group had higher 
VRS and VAS scores due to the lower analgesic 
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effect of morphine alone. The combinations of 
morphine and ketamine or morphine and 
nefopam effectively relieved pain. These 
analgesic combinations act by attenuating 
neurotransmitter release through suppression of 
calcium entry, by enhancing outward movement 
of potassium ions, or by inhibiting adenylate 
cyclase. Ketamine can also prevent the opiate-
associated activation of pro-nociceptive systems, 
which would increase opiate tolerance and thus 
decrease pain further [24]; in accordance, the 
ketamine group exhibited lower VRS and VAS 
scores than the nefopam and saline groups. 
Numerous preclinical and clinical reports have 
demonstrated that both ketamine and nefopam 
improve opioid analgesia [5,6,13,22] due to 
synergistic mechanisms, thus decreasing pain 
intensity. Satisfaction scores were markedly 
higher in both the ketamine and nefopam groups, 
probably due to lower morphine consumption 
and lower VRS and VAS scores. 
 
An adverse effect is an undesired harmful effect 
resulting from a medication or other intervention 
such as surgery. The most frequent adverse 
effects in patients given morphine alone were 
PONV, sweating, pruritus, dry mouth, and RR, 
which have previously been observed [25]. The 
most common side effects in the ketamine group 
were sedation and PONV, whereas sweating, dry 
mouth, and PONV were most common in the 
nefopam group. Kapfer et al [26] also showed 
that PONV, sedation, dry mouth, and sweating 
were the common adverse effects in nefopam 
and ketamine-treated individuals. Lower 
morphine consumption (morphine sparing 
activity) may be the reason for the lower 
incidence of adverse effects in both the ketamine 
and nefopam groups compared with the control 
group. 
 
The present study demonstrates that the 
combination of morphine with low doses of 
ketamine or nefopam, delivered via IV-PCA, 
provides superior analgesic effects with fewer 
adverse events than morphine alone. Even 
though morphine combined with ketamine 
resulted in better outcomes, the exact 
mechanism of ketamine sparing activity is not 
fully understood. Further research is warranted to 
determine the precise molecular mechanism 
underlying the beneficial activity of this analgesic 
regimen.  
 
Limitations of the study 
 
This study is not without limitations. We 
evaluated acute pain for only a short duration (24 
h) after different types of abdominal surgery. 
Moreover, since this was a pilot study, only a 
small number of patients participated, and the 
dose of analgesic used was low. For each 
analgesic, the mode and timing of administration, 
type of surgery, and the dosage used play crucial 
roles in post-operative pain management. Thus, 
finding a good analgesic regimen with an 
effective dosage and mode of administration for 





The findings of the present study demonstrate 
that low-dose ketamine or nefopam infusion with 
morphine has significant opioid-sparing effects, 
and reduce pain intensity and incidence of 
various adverse events. Ketamine administration 
results in superior analgesic effects with a lower 
occurrence of adverse events compared with 
nefopam. Therefore, we recommend the use of 
ketamine combined with morphine for improved 
pain management, to shorten hospitalization, and 
to enhance patient satisfaction. Further research 
with different doses of these analgesics in large 
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